The MedicX Fund Limited Board change (5980X)
February 22 2017 - 12:00PM
UK Regulatory
TIDMMXF
RNS Number : 5980X
The MedicX Fund Limited
22 February 2017
Press Release
For immediate release
22 February 2017
MedicX Fund Limited
("MedicX Fund", "the Fund" or "the Company")
Board change
MedicX Fund (LSE: MXF), the specialist primary care
infrastructure investor in modern, purpose-built, primary
healthcare properties in the United Kingdom and Ireland, today
announces the appointment of Helen Mahy to the Board as a
non-executive director with effect from 1 April 2017.
Helen is chairman of The Renewables Infrastructure Group
Limited, a FTSE 250 investment company, and is a non-executive
director of SSE plc and of SVG Capital plc, each listed on the
London Stock Exchange, and of Bonheur ASA, a company listed on the
Oslo Stock Exchange. Helen qualified as a barrister and was an
Associate of the Chartered Insurance Institute. In 2015 she was
awarded a CBE for services to business and voluntary service,
particularly to the legal profession and diversity in the
workplace. Helen was formerly Group Company Secretary and General
Counsel of National Grid plc until she retired in 2013.
David Staples, Chairman of MedicX Fund, commented:
"As I explained in my Chairman's Statement in our Annual Report
published in December, the Board is working through its succession
plans. In line with those plans, we are delighted to welcome Helen
to the Board. Her expertise in legal matters and corporate
governance, together with her experience in the infrastructure
sector, will be of great benefit to the Company and the Board."
There is no further information to be disclosed under Listing
Rule 9.6.13R.
End
For further information please contact:
MedicX Fund +44 (0) 1481 723 450
David Staples, Chairman
Octopus Healthcare Group +44 (0) 20 3142 4820
Mike Adams, Chief Executive Officer
Canaccord Genuity
Andrew Zychowski/Helen Goldsmith +44 (0) 20 7523 8000
Buchanan +44 (0) 20 7466 5000
Charles Ryland/Vicky Hayns
Information on MedicX Fund Limited
MedicX Fund Limited (the "Fund" or the "Company", or together
with its subsidiaries, the "Group") is the specialist primary care
infrastructure investor in modern, purpose-built primary healthcare
properties in the United Kingdom and Ireland, listed on the London
Stock Exchange, with a portfolio comprising 152 properties.
The Investment Adviser to the Company is Octopus Healthcare
Adviser Ltd, which is part of the Octopus Healthcare group. Octopus
Healthcare invests in and develops properties as well as creating
partnerships to deliver innovative healthcare buildings to improve
the health, wealth and wellbeing of the UK. It currently manages
over GBP1 billion of healthcare investments across a number of
platforms, with a focus on five core areas: GP surgeries, care
homes, special education schools, retirement housing and private
hospitals. Octopus Healthcare is part of the Octopus group, a
fast-growing UK fund management business with leading positions in
several specialist sectors including healthcare property, energy,
property finance and smaller company investing. Octopus manages
GBP6 billion of funds for more than 50,000 retail and institutional
investors.
Octopus Healthcare Adviser Ltd is authorised and regulated by
the Financial Conduct Authority.
The Company's website address is www.medicxfund.com. Neither the
contents of the Company's website nor the contents of any website
accessible from hyperlinks on the Company's website (or any other
website), nor the contents of any website accessible from
hyperlinks within this announcement, are incorporated into, or
forms part of, this announcement.
The Company's Legal Entity Identifier is
2138008POF35FTNFCB25.
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOAUUVNRBBAUUAR
(END) Dow Jones Newswires
February 22, 2017 12:00 ET (17:00 GMT)
Medicx (LSE:MXF)
Historical Stock Chart
From Apr 2024 to May 2024
Medicx (LSE:MXF)
Historical Stock Chart
From May 2023 to May 2024